Transcutaneous acupoint electrical stimulation improves postoperative sleep of patients with gastrointestinal tumors by regulating the Nrf2/ARE signal pathway
- Conditions
- gastrointestinal tumor
- Registration Number
- ITMCTR2100005469
- Lead Sponsor
- Xuzhou Traditional Chinese Medicine Hospital Affiliated to Nanjing University of Chinese Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- Not specified
1.Patients undergoing elective laparoscopic gastrointestinal tumor surgery
2.Age: 18 to 75 years old
3.American Association of Anesthesiologists (ASA) grade I to III
4.BMI 18.5kg/m2 - 28kg/m2
5.Preoperative clinical tumor TNM staging: cTis-3N0-1M0 (refer to AJCC/UICC 8th edition TNM staging)
1. PSQI>7 points. 2.Sleep apnea, or moderate or more snoring. 3. Preoperative sinus bradycardia (heart rate less than 50 beats/min) or sinus node disease, second-degree or third-degree atrioventricular block, and pacemaker. 4.Long-term use of anticonvulsants, antidepressants or other psychotropic drugs. 5. Those who are highly sensitive or allergic to the drugs or equipment in this study. 6.Severe heart, liver or kidney disease. 7. Participated in other clinical trials in the past 3 months. 8.Hearing and language communication barriers, unable to communicate effectively with doctors. 9. Patients who are pregnant or breastfeeding. 10.Patients with fever or infection before surgery.11.Patients who live with critically ill patients or live in a ward with> 3 persons.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method AIS score;PSQI score;
- Secondary Outcome Measures
Name Time Method HRV physiological data;Time of first air exhaust after operation;Liquid in and out;operation time;VAS score;Anesthesia time;Intraoperative remedies;Intraoperative blood pressure;Analgesic use;Body temperature changes;Hospital stay;Adverse events and medication;